arginine vasopressin has been researched along with Diabetes Mellitus, Type 2 in 32 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (15.63) | 18.7374 |
| 1990's | 7 (21.88) | 18.2507 |
| 2000's | 6 (18.75) | 29.6817 |
| 2010's | 13 (40.63) | 24.3611 |
| 2020's | 1 (3.13) | 2.80 |
| Authors | Studies |
|---|---|
| Matyjaszek-Matuszek, B; Szmygin, H; Szydełko, J | 1 |
| Alvarez-Aguilar, C; Alvarez-Paredes, AR; García-López, E; Gómez-García, A; Gu, HF; Higareda-Mendoza, AE; Lindholm, B; Rashid-Qureshi, A; Stenvikel, P; Villela-Torres, ML | 1 |
| Annunziata, G; Barrea, L; Colao, A; Di Somma, C; Muscogiuri, G; Orio, F; Savastano, S; Vecchiarini, M | 1 |
| Horibata, Y; Kawasoe, Y; Murakami, T; Niwa, K; Tateno, S | 1 |
| Buijs, RM; de Goede, P; Hogenboom, R; Kalsbeek, A; Kalsbeek, MJ; Koenen, M; Korpel, NL; Romijn, JA; Swaab, DF; Yi, CX | 1 |
| Alkhalaf, A; Bakker, SJ; Bilo, HJ; Boertien, WE; de Jong, PE; Drion, I; Gansevoort, RT; Groenier, KH; Kleefstra, N; Riphagen, IJ; Struck, J | 1 |
| Alkhalaf, A; Bakker, SJ; Bilo, HJ; Boertien, WE; Gansevoort, RT; Groenier, KH; Kleefstra, N; Navis, G; Riphagen, IJ; Struck, J; van Hateren, KJ | 1 |
| Alhenc-Gelas, F; Bankir, L; Bellili-Munoz, N; Bouby, N; Fumeron, F; Hadjadj, S; Marre, M; Matallah, N; Mohammedi, K; Potier, L; Roussel, R; Taveau, C; Velho, G | 1 |
| Bech, JN; Hansen, AB; Jensen, JM; Larsen, T; Mose, FH; Pedersen, EB | 1 |
| Andersen, UB; Asferg, CL; Goetze, JP; Jeppesen, JL; Linneberg, A | 1 |
| Balkau, B; Bankir, L; Bouby, N; El Boustany, R; Fumeron, F; Marre, M; Mohammedi, K; Potier, L; Roussel, R; Tichet, J; Velho, G | 1 |
| Wang, X; Wu, XX; Zhao, Q; Zhou, J | 1 |
| Ishida, K; Kamata, K; Kobayashi, T; Matsumoto, T; Nakayama, N | 1 |
| Choi, JH; Hwang, IK; Kim, IY; Kim, YN; Lee, CH; Park, IS; Seong, JK; Shin, JH; Won, MH; Yi, SS; Yoon, YS | 1 |
| Nakamura, N | 1 |
| Agha, A; Baylis, P; Finucane, F; Morris, A; Sherlock, M; Smith, D; Thompson, CJ | 1 |
| Burrell, LM; Calafiore, P; Jerums, G; MacIsaac, RJ; Srivastava, PM; Thomas, MC | 1 |
| Dünser, MW; Hasibeder, WR; Jochberger, S; Luckner, G; Mayr, VD; Wenzel, V | 1 |
| Bartz, JA; McInnes, LA | 1 |
| Hwang, IK; Kim, IY; Kim, YN; Lee, IS; Pak, SI; Seong, JK; Yi, SS; Yoon, YS | 1 |
| Ali, S; Bapna, C; Sowers, JR; Standley, PR | 1 |
| Miura, Y; Nakano, H; Nakayama, M; Suzuki, S; Tsuchida, H; Yamada, K; Yoshida, S | 1 |
| Iizuka, T; Nishikawa, T; Omura, M; Saito, I; Yoshida, S | 1 |
| Hashimoto, K; Nishioka, T; Numata, Y; Suemaru, S; Takao, T; Tojo, C | 1 |
| Azam, H; Baylis, PH; McKenna, K; Morris, AD; Newton, RW; Thompson, CJ | 1 |
| Braatvedt, G; Corrall, RJ; Newrick, PG; Penney, M; Walters, G | 1 |
| Ishibashi, M; Kamoi, K; Yamaji, T | 1 |
| Bar, A; Darocha, Z; Duława, J; Grzeszczak, W; Klin, M; Kokot, F | 1 |
| Cignarelli, M; Coratelli, P; Cospite, R; De Pergola, G; Giorgino, R; Narelli, GM; Passavanti, G; Paternostro, A; Romanazzi, V | 1 |
| Fukushima, H; Ichinose, K; Kishikawa, H; Miyata, T; Shichiri, M; Shinohara, M; Suzaki, K; Takeda, H | 1 |
| Duława, J; Grzeszczak, W; Kokot, F; Wiecek, A | 1 |
| Gavras, H; Gavras, I; Mulinari, RA; Ribeiro, AB; Saad, CI; Zanella, MT | 1 |
2 review(s) available for arginine vasopressin and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Copeptin as a novel biomarker of cardiometabolic syndrome.
Topics: Arginine Vasopressin; Biomarkers; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Glycopeptides; Humans; Metabolic Syndrome; Neurophysins; Predictive Value of Tests; Protein Precursors; Vasopressins | 2021 |
Water intake keeps type 2 diabetes away? Focus on copeptin.
Topics: Animals; Arginine Vasopressin; Biomarkers; Diabetes Mellitus, Type 2; Drinking; Glucagon; Glycopeptides; Humans; Insulin; Vasopressins | 2018 |
3 trial(s) available for arginine vasopressin and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Effect of atorvastatin on renal NO availability and tubular function in patients with stage II-III chronic kidney disease and type 2 diabetes.
Topics: Aged; Arginine Vasopressin; Atorvastatin; Atrial Natriuretic Factor; Blood Pressure; Cross-Over Studies; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Glomerular Filtration Rate; Heart Rate; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney Tubules; Male; Middle Aged; Natriuretic Peptide, Brain; Nitric Oxide; omega-N-Methylarginine; Pulse Wave Analysis; Pyrroles; Renal Insufficiency, Chronic; Treatment Outcome; Vascular Stiffness; Vasopressins | 2014 |
Increased platelet cytosolic calcium responses to low density lipoprotein in type II diabetes with and without hypertension.
Topics: Adult; Aged; Arginine Vasopressin; Blood Platelets; Blood Pressure; Calcium; Cholesterol, LDL; Cytosol; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Female; Humans; Hyperinsulinism; Hypertension; Insulin; Insulin Resistance; Male; Middle Aged; Receptors, Lipoprotein; Time Factors | 1993 |
Short-term clinical trial of 1-(1-[4-(3-acetylaminopropoxy)-benzoyl]-4-piperidyl)-3, 4-dihydro-2(1H)-quinolinone in patients with diabetic nephropathy. Possible effectiveness of the specific vasopressin V1 receptor antagonist for reducing albuminuria in p
Topics: Albuminuria; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Blood Glucose; Blood Pressure; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Heart Rate; Humans; Male; Middle Aged; Piperidines; Quinolones; Saline Solution, Hypertonic | 1996 |
27 other study(ies) available for arginine vasopressin and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Copeptin Plasma Levels are Associated with Decline of Renal Function in Patients with Type 2 Diabetes Mellitus.
Topics: Arginine Vasopressin; Biomarkers; Cystatin C; Diabetes Mellitus, Type 2; Female; Glomerular Filtration Rate; Glycopeptides; Humans; Male; Middle Aged; Neurophysins; Protein Precursors; Renal Insufficiency, Chronic; Vasopressins | 2018 |
Relationship between non-osmotic arginine vasopressin secretion and hemoglobin A1c levels in adult patients with congenital heart disease.
Topics: Adult; Arginine Vasopressin; Biomarkers; Diabetes Mellitus, Type 2; Disease Progression; Female; Glycated Hemoglobin; Heart Defects, Congenital; Heart Failure; Humans; Logistic Models; Male; Middle Aged; Natriuretic Peptide, Brain; Young Adult | 2019 |
Loss of arginine vasopressin- and vasoactive intestinal polypeptide-containing neurons and glial cells in the suprachiasmatic nucleus of individuals with type 2 diabetes.
Topics: Arginine Vasopressin; Circadian Rhythm; Diabetes Mellitus, Type 2; Humans; Life Style; Microglia; Neuroglia; Neurons; Neuropeptides; Neurophysins; Protein Precursors; Suprachiasmatic Nucleus; Vasoactive Intestinal Peptide; Vasopressins | 2019 |
Copeptin, a surrogate marker for arginine vasopressin, is associated with declining glomerular filtration in patients with diabetes mellitus (ZODIAC-33).
Topics: Aged; Albumins; Angiotensin-Converting Enzyme Inhibitors; Arginine Vasopressin; Biomarkers; Creatinine; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Female; Glomerular Filtration Rate; Glycopeptides; Humans; Male; Middle Aged; Renin-Angiotensin System | 2013 |
Copeptin, a surrogate marker for arginine vasopressin, is associated with cardiovascular and all-cause mortality in patients with type 2 diabetes (ZODIAC-31).
Topics: Aged; Arginine Vasopressin; Biomarkers; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Female; Glycopeptides; Humans; Male; Middle Aged; Sex Factors | 2013 |
Plasma copeptin and renal outcomes in patients with type 2 diabetes and albuminuria.
Topics: Aged; Albuminuria; Arginine Vasopressin; Biomarkers; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Glomerular Filtration Rate; Glycopeptides; Humans; Kidney Failure, Chronic; Kidney Function Tests; Male; Middle Aged | 2013 |
Copeptin, a surrogate marker for arginine vasopressin secretion, is associated with higher glucose and insulin concentrations but not higher blood pressure in obese men.
Topics: Adipose Tissue; Arginine Vasopressin; Biomarkers; Blood Glucose; Body Fat Distribution; Body Mass Index; Diabetes Mellitus, Type 2; Glucose Intolerance; Glycopeptides; Humans; Hypertension; Insulin; Male; Middle Aged; Obesity | 2014 |
Plasma Copeptin, AVP Gene Variants, and Incidence of Type 2 Diabetes in a Cohort From the Community.
Topics: Adult; Alleles; Arginine Vasopressin; Blood Glucose; Cohort Studies; Diabetes Mellitus, Type 2; Female; France; Genetic Association Studies; Glycopeptides; Humans; Hyperglycemia; Incidence; Insulin; Insulin Resistance; Male; Middle Aged; Polymorphism, Single Nucleotide; Prospective Studies; Sex Factors | 2016 |
Elevated plasma levels of copeptin linked to diabetic retinopathy in type 2 diabetes.
Topics: Aged; Arginine Vasopressin; Asian People; Biomarkers; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Female; Glycopeptides; Humans; Insulin Resistance; Logistic Models; Male; Middle Aged; ROC Curve | 2017 |
Involvement of NO and MEK/ERK pathway in enhancement of endothelin-1-induced mesenteric artery contraction in later-stage type 2 diabetic Goto-Kakizaki rat.
Topics: Angiotensin II; Animals; Arginine Vasopressin; Butadienes; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Disease Models, Animal; Disease Progression; Dose-Response Relationship, Drug; Endothelin-1; Endothelins; Enzyme Inhibitors; Extracellular Signal-Regulated MAP Kinases; Flavonoids; Male; MAP Kinase Kinase Kinases; Mesenteric Arteries; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Nitriles; Nitroarginine; Nitroprusside; Oligopeptides; Peptide Fragments; Peptides, Cyclic; Piperidines; Rats; Rats, Wistar; Receptor, Endothelin A; Receptor, Endothelin B; Signal Transduction; Vasoconstriction; Vasodilation | 2009 |
Regulatory mechanism of hypothalamo-pituitary-adrenal (HPA) axis and neuronal changes after adrenalectomy in type 2 diabetes.
Topics: Adrenalectomy; Analysis of Variance; Animals; Arginine Vasopressin; Blood Glucose; Blotting, Western; Corticosterone; Corticotropin-Releasing Hormone; Diabetes Mellitus, Type 2; Female; Glucose Tolerance Test; Hypothalamo-Hypophyseal System; Hypothalamus; Immunohistochemistry; Male; Neurons; Pituitary Gland; Pituitary-Adrenal System; Radioimmunoassay; Rats; Rats, Zucker; Receptors, Glucocorticoid; Reverse Transcriptase Polymerase Chain Reaction | 2010 |
Reduced aldehyde dehydrogenase activity and arginine vasopressin receptor 2 expression in the kidneys of male TALLYHO/JngJ mice of prediabetic age.
Topics: Aldehyde Dehydrogenase; Animals; Arginine Vasopressin; Bowman Capsule; Case-Control Studies; Diabetes Mellitus, Type 2; Disease Models, Animal; Female; Kidney; Male; Matched-Pair Analysis; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Organ Size; Receptors, Vasopressin; Reference Values; Sex Factors; Water-Electrolyte Balance | 2011 |
Attenuation of vasopressin-induced antidiuresis in poorly controlled type 2 diabetes.
Topics: Aged; Arginine Vasopressin; Diabetes Mellitus, Type 2; Diuresis; Female; Glycated Hemoglobin; Humans; Kidney; Linear Models; Male; Middle Aged; Osmolar Concentration; Sensory Thresholds; Thirst; Urine; Vasopressins; Water Deprivation; Water-Electrolyte Balance | 2004 |
Diastolic dysfunction is associated with anaemia in patients with Type II diabetes.
Topics: Aged; Anemia; Arginine Vasopressin; Biomarkers; C-Reactive Protein; Diabetes Complications; Diabetes Mellitus, Type 2; Diastole; Female; Heart Diseases; Hemoglobins; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Ultrasonography | 2006 |
[Vasopressin as a rescue vasopressor agent. Treatment of selected cardiogenic shock states].
Topics: Aged; Aged, 80 and over; Arginine Vasopressin; Blood Pressure; Critical Illness; Diabetes Mellitus, Type 2; Female; Heart Failure; Heart Rate; Humans; Hyperlipidemias; Hypertension; Male; Middle Aged; Myocardial Infarction; Postoperative Complications; Pulmonary Wedge Pressure; Sepsis; Shock, Cardiogenic; Treatment Outcome; Vasoconstrictor Agents | 2007 |
CD38 regulates oxytocin secretion and complex social behavior.
Topics: ADP-ribosyl Cyclase 1; Animals; Arginine Vasopressin; Diabetes Mellitus, Type 2; Neurons; Oxytocin; Social Behavior | 2007 |
Enhanced expressions of arginine vasopressin (Avp) in the hypothalamic paraventricular and supraoptic nuclei of type 2 diabetic rats.
Topics: Animals; Arginine Vasopressin; Blotting, Western; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Female; Immunohistochemistry; Male; Paraventricular Hypothalamic Nucleus; Rats; Rats, Zucker; Supraoptic Nucleus | 2008 |
The effect of OPC-21268, an oral, nonpeptide arginine vasopressin V1 receptor antagonist, on a patient with congestive heart failure.
Topics: Adult; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Blood Pressure; Diabetes Mellitus, Type 2; Female; Heart Failure; Heart Rate; Humans; Kidney Failure, Chronic; Piperidines; Quinolones | 1993 |
Hypothalamic-pituitary-adrenal axis in WBN/Kob rats with non-insulin dependent diabetes mellitus.
Topics: Adrenal Glands; Adrenocorticotropic Hormone; Animals; Arginine Vasopressin; Blood Glucose; Body Weight; Brain; Corticosterone; Corticotropin-Releasing Hormone; Diabetes Mellitus, Type 2; Hypothalamus; Insulin; Iodine Radioisotopes; Male; Organ Size; Pituitary Gland; Rats; Rats, Mutant Strains; Rats, Wistar; Thymus Gland | 1996 |
Exaggerated vasopressin secretion and attenuated osmoregulated thirst in human survivors of hyperosmolar coma.
Topics: Aged; Aged, 80 and over; Arginine Vasopressin; Blood; Dehydration; Diabetes Mellitus, Type 2; Female; Humans; Hyperglycemic Hyperosmolar Nonketotic Coma; Hypernatremia; Linear Models; Male; Middle Aged; Osmolar Concentration; Thirst; Vasopressins; Water Deprivation; Water-Electrolyte Balance | 1999 |
Studies of acquired sustained hypernatraemia occurring in a diabetic patient.
Topics: Arginine Vasopressin; Diabetes Mellitus, Type 2; Humans; Hypernatremia; Male; Middle Aged; Saline Solution, Hypertonic; Thirst; Water; Water Deprivation | 1992 |
Thirst and plasma levels of vasopressin, angiotensin II and atrial natriuretic peptide in patients with non-insulin-dependent diabetes mellitus.
Topics: Adult; Angiotensin II; Arginine Vasopressin; Atrial Natriuretic Factor; Blood Pressure; Diabetes Mellitus, Type 2; Female; Heart Rate; Humans; Male; Middle Aged; Reference Values; Renin; Thirst | 1991 |
Water-immersion-induced alterations of atrial natriuretic peptide, plasma renin activity, aldosterone and vasopressin in diabetic patients.
Topics: Adult; Aldosterone; Arginine Vasopressin; Atrial Natriuretic Factor; Blood Pressure; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Humans; Immersion; Male; Middle Aged; Reference Values; Renin | 1989 |
Renal excretion of arginine-vasopressin in microalbuminuric diabetic patients.
Topics: Aged; Albuminuria; Arginine Vasopressin; Diabetes Mellitus, Type 2; Female; Humans; Male; Middle Aged; Osmolar Concentration; Potassium; Sodium | 1989 |
Effect of alpha 2-adrenoceptor antagonist on platelet activation during insulin-induced hypoglycaemia in type 2 (non-insulin-dependent) diabetes mellitus.
Topics: Arginine Vasopressin; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Epinephrine; Female; Humans; Hypoglycemia; Hypoglycemic Agents; Imidazoles; In Vitro Techniques; Insulin; Male; Middle Aged; Platelet Aggregation; Reference Values | 1988 |
[Effect of water immersion on plasma renin activity, vasopressin and aldosterone level in diabetics].
Topics: Aldosterone; Arginine Vasopressin; Blood Volume; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Female; Humans; Immersion; Male; Middle Aged; Renin; Water-Electrolyte Balance | 1987 |
The role of vasopressin in blood pressure maintenance in diabetic orthostatic hypotension.
Topics: Arginine Vasopressin; Blood Pressure; Diabetes Mellitus, Type 2; Female; Heart Rate; Humans; Hypotension, Orthostatic; Male | 1988 |